Can prescription medications cause false positives?

Yes, some prescription medications can cause false positives on initial drug screening tests, particularly immunoassay-based screens. These results occur when a test reacts to a substance with a chemical structure similar to the drug being screened for.

False positives are most commonly associated with preliminary urine screens rather than confirmatory laboratory testing. Certain antidepressants, decongestants, antibiotics, and medications for pain or attention disorders have been reported to trigger unexpected results on some screening panels. For example, medications that affect the central nervous system may cross-react with assays designed to detect stimulants, opioids, or benzodiazepines.

Screening tests are intentionally designed to be sensitive rather than specific. Their purpose is to flag potential positives quickly, not to make definitive determinations. Because of this design, cross-reactivity is a known limitation. Confirmatory testing methods, such as gas or liquid chromatography combined with mass spectrometry, are used to precisely identify substances and distinguish prescribed medications from illicit drugs.

False positives do not indicate wrongdoing or misuse. They reflect the technical limits of screening assays and the complexity of drug metabolism. Reporting current prescription use before or during testing helps laboratories interpret results accurately.

Understanding how false positives occur helps clarify why screening results are considered preliminary. Definitive test outcomes are based on confirmatory analysis, which virtually eliminates cross-reactivity and provides substance-specific identification.